Cargando…

Exceptional response to PD-1 inhibition immunotherapy in advanced metastatic osteosarcoma with tumor site infection

Recent clinical trials have demonstrated a lack of activity of immune checkpoint inhibitors (ICIs) against osteosarcoma. Previous clinical observations have demonstrated a potential immune-stimulatory effect of tumor site infection for osteosarcoma patients. However, whether such infection could aug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Meng, Bao, Qiyuan, Zhang, Zhusheng, Wang, Beichen, Liu, Zhuochao, Wen, Junxiang, Wan, Rong, Shen, Yuhui, Zhang, Weibin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472102/ http://dx.doi.org/10.1136/jitc-2022-004673

Ejemplares similares

The Outcome of Discontinuing Tyrosine Kinase Inhibitors in Advanced Sarcoma Following a Favorable Tumor Response to Antiangiogenics Therapy
por: Zhang, Zhusheng, et al.
Publicado: (2022)

Construction and validation of a novel apoptosis-associated prognostic signature related to osteosarcoma metastasis and immune infiltration
por: Fu, Yucheng, et al.
Publicado: (2022)

Exploration and Validation of a Novel Inflammatory Response-Associated Gene Signature to Predict Osteosarcoma Prognosis and Immune Infiltration
por: Fu, Yucheng, et al.
Publicado: (2021)

MicroRNA-200a induces immunosuppression by promoting PTEN-mediated PD-L1 upregulation in osteosarcoma
por: Liu, Zhuochao, et al.
Publicado: (2020)

Development and Validation of a Hypoxia-Associated Prognostic Signature Related to Osteosarcoma Metastasis and Immune Infiltration
por: Fu, Yucheng, et al.
Publicado: (2021)

Development and analysis of long non-coding RNA-associated competing endogenous RNA network for osteosarcoma metastasis
por: Fu, Yucheng, et al.
Publicado: (2021)

Thrombospondin‐1 induced programmed death‐ligand 1‐mediated immunosuppression by activating the STAT3 pathway in osteosarcoma
por: Liu, Zhuochao, et al.
Publicado: (2021)

Antitumor effect of focal adhesion kinase inhibitor PF562271 against human osteosarcoma in vitro and in vivo
por: Hu, Chuanzhen, et al.
Publicado: (2017)

Targeting autophagy enhances atezolizumab-induced mitochondria-related apoptosis in osteosarcoma
por: Liu, Zhuochao, et al.
Publicado: (2021)

Small cell osteosarcoma of the rib: An exceptional localization
por: Abid, Walid, et al.
Publicado: (2022)

Impaired Limb Functional Outcome of Peripheral Nerve Regeneration Is Marked by Incomplete Recovery of Paw Muscle Atrophy and Brain Functional Connectivity in a Rat Forearm Nerve Repair Model
por: Bao, Qiyuan, et al.
Publicado: (2021)

CMS : An exceptional load for an exceptional work site
Publicado: (2001)

Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy
por: Ikeda, Sadakatsu, et al.
Publicado: (2016)

The Updated Status and Future Direction of Immunotherapy Targeting B7-H1/PD-1 in Osteosarcoma
por: Fan, Meng-ke, et al.
Publicado: (2021)

Thrombospondin-1 promotes cell migration, invasion and lung metastasis of osteosarcoma through FAK dependent pathway
por: Hu, Chuanzhen, et al.
Publicado: (2017)

The Heterogeneity of Infiltrating Macrophages in Metastatic Osteosarcoma and Its Correlation with Immunotherapy
por: Wang, Zhanchao, et al.
Publicado: (2021)

Novel Immunotherapies for Osteosarcoma
por: Lu, Yubao, et al.
Publicado: (2022)

Irradiation enhanced the effects of PD-1 blockade in brain metastatic osteosarcoma
por: Xia, Liming, et al.
Publicado: (2018)

Exceptional Response to A Single Cycle of Immunotherapy in a Lynch Syndrome Patient with Metastatic Pancreatic Adenocarcinoma
por: Patil, Neha R., et al.
Publicado: (2020)

One dose of immunotherapy leading to an exceptional and durable response in a patient with metastatic renal cell carcinoma
por: Wade, Louise, et al.
Publicado: (2019)

Case report: Metastatic urothelial cancer with an exceptional response to immunotherapy and comprehensive understanding of the tumor and the tumor microenvironment
por: Sternberg, Cora N., et al.
Publicado: (2022)

Adoptive transfer of TILs plus anti-PD1 therapy: An alternative combination therapy for treating metastatic osteosarcoma
por: Wang, Chao, et al.
Publicado: (2020)

Transporting "exceptional cargo" on the CERN sites
por: EN Department
Publicado: (2012)

Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma
por: Lussier, Danielle M, et al.
Publicado: (2015)

Optimizing the Treatment Schedule of Radiotherapy Combined With Anti-PD-1/PD-L1 Immunotherapy in Metastatic Cancers
por: Kong, Yuehong, et al.
Publicado: (2021)

Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality
por: Yu, Lei, et al.
Publicado: (2022)

Exceptional Thermoelectric Properties of Bilayer GeSe: First Principles Calculation
por: Fan, Qiang, et al.
Publicado: (2022)

MCM4 Is a Novel Biomarker Associated With Genomic Instability, BRCAness Phenotype, and Therapeutic Potentials in Soft-Tissue Sarcoma
por: Liu, Qi, et al.
Publicado: (2021)

Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy
por: Sundara, Yayan T., et al.
Publicado: (2016)

MLTI-08. AN EXCEPTIONAL INTRACRANIAL RESPONSE TO REPEAT RADIATION AND IMMUNOTHERAPY IN A PATIENT WITH METASTATIC, POORLY DIFFERENTIATED ADENOCARCINOMA OF THE LUNG
por: Sumrall, Ashley, et al.
Publicado: (2019)

Tantalum–Zirconium Co‐Doped Metal–Organic Frameworks Sequentially Sensitize Radio–Radiodynamic–Immunotherapy for Metastatic Osteosarcoma
por: Li, Tao, et al.
Publicado: (2023)

Exceptional Response with Immunotherapy in a Patient with Anaplastic Thyroid Cancer
por: Kollipara, Revathi, et al.
Publicado: (2017)

Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma
por: Zhang, Xingming, et al.
Publicado: (2019)

Metastatic Spread of Osteosarcoma
por: Price, C. H. G., et al.
Publicado: (1973)

The metastatic patterns of osteosarcoma.
por: Jeffree, G. M., et al.
Publicado: (1975)

Clinical factors affecting prognosis of limb osteosarcoma in China: a multicenter retrospective analysis
por: Han, Jia, et al.
Publicado: (2020)

Magnetic resonance imaging features for the differential diagnosis of local recurrence of bone sarcoma after prosthesis replacement
por: Qin, Le, et al.
Publicado: (2018)

Modification of the Tumor Microenvironment Enhances Anti-PD-1 Immunotherapy in Metastatic Melanoma
por: Shi, Guilan, et al.
Publicado: (2022)

Low insulin-like growth factor-1 level predicts survival in humans with exceptional longevity
por: Milman, Sofiya, et al.
Publicado: (2014)

Exceptional Response to Systemic Therapy in Advanced Metastatic Gastric Cancer: A Case Report
por: Colton, Bradley, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_glm21sjfrvi071mse42q4ql4hs